137 related articles for article (PubMed ID: 34756924)
1. Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.
Pucci S; Bolchi C; Bavo F; Pallavicini M; De Palma C; Renzi M; Fucile S; Benfante R; Di Lascio S; Lattuada D; Bessereau JL; D'Alessandro M; Risson V; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2022 Jan; 175():105959. PubMed ID: 34756924
[TBL] [Abstract][Full Text] [Related]
2. Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors.
Pucci S; Fasoli F; Moretti M; Benfante R; Di Lascio S; Viani P; Daga A; Gordon TJ; McIntosh M; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2021 Jan; 163():105336. PubMed ID: 33276105
[TBL] [Abstract][Full Text] [Related]
3. Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan.
Bavo F; Pucci S; Fasoli F; Lammi C; Moretti M; Mucchietto V; Lattuada D; Viani P; De Palma C; Budriesi R; Corradini I; Dowell C; McIntosh JM; Clementi F; Bolchi C; Gotti C; Pallavicini M
J Med Chem; 2018 Dec; 61(23):10531-10544. PubMed ID: 30403486
[TBL] [Abstract][Full Text] [Related]
4. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
[TBL] [Abstract][Full Text] [Related]
5. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
Maggi L; Palma E; Eusebi F; Moretti M; Balestra B; Clementi F; Gotti C
Br J Pharmacol; 1999 Jan; 126(1):285-95. PubMed ID: 10051147
[TBL] [Abstract][Full Text] [Related]
6. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti C; Carbonnelle E; Moretti M; Zwart R; Clementi F
Behav Brain Res; 2000 Aug; 113(1-2):183-92. PubMed ID: 10942044
[TBL] [Abstract][Full Text] [Related]
7. From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue.
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Eaton B; Lucero L; Gotti C; Moretti M; Whiteaker P; Bolchi C
J Med Chem; 2022 Jul; 65(14):10079-10097. PubMed ID: 35834819
[TBL] [Abstract][Full Text] [Related]
8. Subtype-Selective Peptide and Protein Neurotoxic Inhibitors of Nicotinic Acetylcholine Receptors Enhance Proliferation of Patient-Derived Glioblastoma Cell Lines.
Gondarenko E; Mazur D; Masliakova M; Ryabukha Y; Kasheverov I; Utkin Y; Tsetlin V; Shahparonov M; Kudryavtsev D; Antipova N
Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393158
[TBL] [Abstract][Full Text] [Related]
9. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.
Giraudo A; Pallavicini M; Bolchi C
Pharmacol Res; 2023 Jul; 193():106801. PubMed ID: 37236412
[TBL] [Abstract][Full Text] [Related]
10. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors.
Gotti C; Balestra B; Moretti M; Rovati GE; Maggi L; Rossoni G; Berti F; Villa L; Pallavicini M; Clementi F
Br J Pharmacol; 1998 Jul; 124(6):1197-206. PubMed ID: 9720791
[TBL] [Abstract][Full Text] [Related]
11. New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
Dallanoce C; Richter K; Stokes C; Papotto C; Andleeb H; Thakur GA; Kerr A; Grau V; Papke RL
ACS Chem Neurosci; 2024 Feb; 15(4):827-843. PubMed ID: 38335726
[TBL] [Abstract][Full Text] [Related]
12. MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.
Brown KC; Lau JK; Dom AM; Witte TR; Luo H; Crabtree CM; Shah YH; Shiflett BS; Marcelo AJ; Proper NA; Hardman WE; Egleton RD; Chen YC; Mangiarua EI; Dasgupta P
Angiogenesis; 2012 Mar; 15(1):99-114. PubMed ID: 22198237
[TBL] [Abstract][Full Text] [Related]
13. Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum.
Guerra-Álvarez M; Moreno-Ortega AJ; Navarro E; Fernández-Morales JC; Egea J; López MG; Cano-Abad MF
J Neurochem; 2015 May; 133(3):309-19. PubMed ID: 25650007
[TBL] [Abstract][Full Text] [Related]
14. Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Oh H; Kneisley DL; Eaton B; Lucero L; Gotti C; Clementi F; Whiteaker P; Bolchi C
J Med Chem; 2023 Jan; 66(1):306-332. PubMed ID: 36526469
[TBL] [Abstract][Full Text] [Related]
15. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
[TBL] [Abstract][Full Text] [Related]
16. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
[TBL] [Abstract][Full Text] [Related]
17. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
18. Calcium imaging with genetically encoded sensor Case12: Facile analysis of α7/α9 nAChR mutants.
Shelukhina I; Spirova E; Kudryavtsev D; Ojomoko L; Werner M; Methfessel C; Hollmann M; Tsetlin V
PLoS One; 2017; 12(8):e0181936. PubMed ID: 28797116
[TBL] [Abstract][Full Text] [Related]
19. Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.
Papke RL; Andleeb H; Stokes C; Quadri M; Horenstein NA
ACS Chem Neurosci; 2022 Mar; 13(5):624-637. PubMed ID: 35167270
[TBL] [Abstract][Full Text] [Related]
20. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
